Fact CheckerSign in

NCT05589675Completed

Evaluation of a New Invitation Procedure to the French Organized Colorectal Cancer Screening Program

Evaluation of the Home Delivery of the Screening Kit, and Impact of a Prior Notification Among New Participants to the National Organized Colorectal Cancer Screening Program (Among New Participants Only)

Source: ClinicalTrials.gov · Last updated 26 Aug 2026

Brief summary (registry, in English)

This is a randomized controlled trial comparing the effect on participation rates to colorectal cancer screening between an intervention arm (invitation letter to the screening program including a FIT test with or without prior notification) and a control arm with the standard of care (invitation letter to visit the GP who will deliver the FIT test).

Status (registry)
Completed
Study type
Interventional
Enrollment
71117 (actual)
First submitted
18 Oct 2022
Start date
1 Apr 2023
Primary completion date
17 Jul 2025
Lead sponsor
International Agency for Research on Cancer
NCT number
NCT05589675

What you commit to

  • Study type: Interventional
  • Participants enrolled: 71117
  • From 1 Apr 2023 to the primary completion date, 17 Jul 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving the reminder letter

Other illness

  • At high or very high risk of colorectal cancer

Age

  • Outside the target age (less than 50 years old, or 75 years and more)

Who the study is looking for

  • Women and men aged 50 to 74 years old
  • Living in the study area (Departments of Ardennes, Meurthe-et-Moselle, and Moselle, France)
  • At moderate risk of colorectal cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter)

Age in the registry: 50 years to 74 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Regional Cancer Screening Coordinating Centre, Ardennes site
Coordinator of this site? Confirm its status
Charleville-MézièresFranceUnknown status
Regional Cancer Screening Coordinating Centre, Moselle Site
Coordinator of this site? Confirm its status
MetzFranceUnknown status
Regional Cancer Screening Coordinating Centre, Meurthe-et-Moselle Site
Coordinator of this site? Confirm its status
NancyFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.